Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| EGenesis | 2024 | Series D | Undisclosed | Cambridge |
| Fractyl Health | 2025 | Post-IPO Equity | Undisclosed | Lexington |
| Volastra Therapeutics | 2025 | Series A | Undisclosed | New York |
| Noetik | 2024 | Grant | Undisclosed | South San Francisco |
| TapestryHealth | 2023 | Debt Financing | Undisclosed | Stratford |
| Bayesian Health | 2021 | Venture - Series Unknown | Undisclosed | New York |
| Septerna | 2023 | Series B | Undisclosed | San Francisco |
| Flourish | 2026 | Series A | Undisclosed | New York |
| Visby Medical | 2025 | Venture - Series Unknown | Undisclosed | San Jose |
| Parabilis Medicines | 2026 | Post-IPO Equity | $305.0M | Cambridge |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 1 | EGenesis | Series D | Undisclosed | Cambridge, United States |
| 2 | Fractyl Health | Post-IPO Equity | Undisclosed | Lexington, United States |
| 3 | Volastra Therapeutics | Series A | Undisclosed | New York, United States |
| 4 | Noetik | Grant | Undisclosed | South San Francisco, United States |
| 5 | TapestryHealth | Debt Financing | Undisclosed | Stratford, United States |
| 6 | Bayesian Health | Venture - Series Unknown | Undisclosed | New York, United States |
| 7 | Septerna | Series B | Undisclosed | San Francisco, United States |
| 8 | Flourish | Series A | Undisclosed | New York, United States |
| 9 | Visby Medical | Venture - Series Unknown | Undisclosed | San Jose, United States |
| 10 | Parabilis Medicines | Post-IPO Equity | $305.0M | Cambridge, United States |
EGenesis is a gene editing and genome engineering company developing human-compatible engineered organs to treat diseases.
Fractyl Health is a biotechnology company that provides curative therapies for metabolic diseases.
Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers.
Noetik is an AI-native biotechnology company that applies machine learning to large-scale human multimodal spatial omics datasets.
TapestryHealth provides telemedicine services including primary care, emergency care, and various health screenings.
Bayesian Health is an adaptive AI platform that offers health systems through clinical AI.
Septerna is a biotech firm unlocking diverse drug discovery potential in G protein-coupled receptors across various diseases.
Flourish Labs combines humans, AI & tech to provide employee coaching and AI-powered peer mental health support.
Visby Medical is a diagnostics company that develops polymerase chain reaction diagnostic tests for the detection of infectious diseases.
Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.
Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.
9amHealth offers a simplified approach to whole body health, focusing on weight loss, diabetes management, and heart health.
ArriVent develops pharmaceutical products to cure presently untreatable cancer.
Beacon Biosignals is a neurotechnology company that brings precision neuroscience into clinical trials and treatments.
Pheast Therapeutics develops checkpoint therapies to harness the innate immune system.
Neumora Therapeutics operates as a clinical-stage biotechnology company.
Spiral Therapeutics is a clinical-stage pharmaceutical company delivering therapies for inner ear disorders.
AdvanCell is a clinical-stage radiopharmaceutical company developing targeted alpha therapies for cancer treatment.
Claris Biotherapeutics develops a topical formulation intended to cure corneal wounds, ulcers, and scars.
Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering.
Avava is a Pioneer precision skin therapy to improve the quality of life for patients around the world.
Affini-T Therapeutics is a biotechnology company developing T-cell therapies for patients suffering from cancer.
Hyperfine makes MRI accessible to every patient regardless of income or resources.
Imperative Care is singularly dedicated to finding meaningful answers to unsolved problems in stroke.
Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach.
Catalio Capital Management has invested in 110 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Catalio Capital Management's top investment sectors include Biotechnology, Health Care, Medical, Life Science, Therapeutics. The firm invests across 25 different industry categories.
Among tracked funding rounds, Parabilis Medicines received $305.0M in a Post-IPO Equity round. Catalio Capital Management's total known invested capital is $5.2B.
Catalio Capital Management's average investment size is $72.8M across its portfolio of 110 companies.
Recent Catalio Capital Management portfolio additions include EGenesis, Fractyl Health, Volastra Therapeutics, Noetik, TapestryHealth. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors